The Marzetti Company (MZTI) Fair Value & Analysis
Consumer Defensive · US · Market cap $2.9B
Analysis
The Marzetti Company (MZTI) currently trades at $108.99, while our model-based Fair Value estimate is $128.15 — implying the stock looks roughly 17.6% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
The Marzetti Company engages in manufacturing and marketing of specialty food products for the retail and foodservice channels in the United States. It operates in two segments, Retail and Foodservice. The company offers frozen garlic breads under the New York Bakery brand; frozen Parkerhouse style yeast and dinner rolls under the Sister Schubert's brand; salad dressings under the Marzetti, Cardini's, Marzetti Simply, and Girard's brands; vegetable and fruit dips under the Marzetti brand; croutons and salad toppings under the New York Bakery, Chatham Village, and Marzetti brands; and frozen pasta under the Marzetti Frozen Pasta brand. It also manufactures and sells various products to brand license agreements, including Olive Garden dressings, Buffalo Wild Wings sauces, Chick-fil-A sauces and dressing, Texas Roadhouse steak sauces and frozen rolls, and Subway sauces. The company sells its products through sales personnel, food brokers, and distributors to retailers and restaurants. …
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.